Insulet (Nasdaq:PODD) has secured a significant legal victory in a patent spat with Korea-based insulin patch pump maker EOFlow. Our sister site, Drug Delivery Business News, reports today that a jury awarded the company hundreds of millions of dollars in damages as a result of misappropriated trade secrets. Both companies develop insulin patch pumps — tubeless, […]
Diabetes
Welcome to MassDevice's Diabetes Hub, your resource for the latest news in diabetes technology. Stay informed about the innovations and business news shaping the diabetes device industry.
Here are top diabetes features from MassDevice and its sister publications (and scroll down to read the latest diabetes device news from MassDevice):
+ The 9 largest diabetes tech companies in the world
+ These diabetes devices are set to launch in 2024
+ The biggest stories from the American Diabetes Association (ADA) 2024 Scientific Sessions
+ These diabetes devices are set to launch in 2024
+ How Dexcom designed a new “life-changing” sensor for even more people with diabetes
+ Embecta CEO sees GLP-1 opportunities as company progresses on insulin patch pump
Latest Diabetes News
Embecta to lay off 118 in Massachusetts following patch pump program discontinuation
Shortly after announcing a major product discontinuation, Embecta (Nasdaq:EMBC) is laying off more than 100 people in Massachusetts. Our sister site, Drug Delivery Business News, reports today that Embecta filed with the state to confirm the layoffs at the end of November. The BD Diabetes spinoff said last month that it plans to discontinue its insulin patch […]
Embecta discontinues insulin patch pump program, plans restructuring
Embecta (Nasdaq:EMBC) today announced that it’s bowing out of a significant diabetes technology market amid a new restructuring effort. Our sister site, Drug Delivery Business News, reports that the BD Diabetes spinoff is discontinuing its insulin patch pump program. This decision also includes a significant restructuring that will lead to a workforce reduction, although Embecta has […]
Medtronic wins FDA nod for new InPen app to support launch with Simplera CGM
Medtronic (NYSE:MDT) today announced a regulatory milestone that supports the rollout of its next-generation CGM. Our sister site, Drug Delivery Business News, reports today that the FDA cleared the medtech giant’s new InPen insulin delivery system application. Clearance paves the way for the launch of the company’s smart multiple daily injection (MDI) system. That system includes […]
Insulet Omnipod 5 is now compatible with Abbott FreeStyle Libre 2 Plus
Insulet (Nasdaq:PODD) today announced a new integration making Omnipod 5 the most connected tubeless automated insulin delivery system in the U.S. Our sister site, Drug Delivery Business News, reports today that the company paired Omnipod 5 with the Abbott FreeStyle Libre 2 Plus CGM. Compatibility in the U.S. comes about eight months after the company integrated […]
Dexcom invests $75M in Oura as companies strike health monitoring partnership
Dexcom (Nasdaq:DXCM) today announced a significant investment and health monitoring partnership involving its CGM technology. Our sister site, Drug Delivery Business News, reports today that the San Diego-based continuous glucose monitor maker invested $75 million in Oura, maker of the Oura Ring, a smart ring that delivers vital sign, sleep, stress, heart health and activity […]
Abbott opens new FreeStyle Libre manufacturing plant in Ireland
Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland. Our sister site, Drug Delivery Business News, reports today that the company opened its plant in Kilkenny in the South-East region of Ireland. The site serves as a global manufacturing center of excellence for Abbott’s Diabetes Care business. […]
What diabetes tech companies are doing on World Diabetes Day 2024
World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after year. This date serves as a time to recognize these innovations as it marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. The […]
Insulet stock rises on Q3 beat, raised sales guidance
Insulet (Nasdaq:PODD) once again posted significant year-over-year growth as Omnipod revenues continue to rise. Our sister site, Drug Delivery Business News, reports today that the company’s third-quarter financial results include sales of $543.9 million for the three months ended Sept. 30, 2024, leading to a 49.3% bottom-line gain on a sales increase of 25.7%. The company […]
Tandem stock rises on 31% Q3 sales growth, raised guidance
Tandem Diabetes Care (Nasdaq:TNDM) stock is on the rise following strong third-quarter financial results from the insulin pump maker. Our sister site, Drug Delivery Business News, reports today that the company topped Wall Street forecasts and raised its full-year guidance following another quarter of growth. As a result, shares of TNDM rose 5% to $35.85 […]
FDA approves Abbott CGMs for use during medical imaging
Abbott (NYSE:ABT) today announced a significant regulatory milestone that could make common medical procedures easier for people with diabetes. Our sister site, Drug Delivery Business News, reports today that the FDA cleared the removal of the imaging contradiction for the FreeStyle Libre 2 and 3 continuous glucose monitors (CGMs) for procedures like X-rays, CT scans and […]